California Public Employees Retirement System’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-6,490
| Closed | -$34K | – | 3569 |
|
2020
Q3 | $34K | Hold |
6,490
| – | – | ﹤0.01% | 3501 |
|
2020
Q2 | $49K | Hold |
6,490
| – | – | ﹤0.01% | 3415 |
|
2020
Q1 | $66K | Hold |
6,490
| – | – | ﹤0.01% | 3211 |
|
2019
Q4 | $101K | Hold |
6,490
| – | – | ﹤0.01% | 3285 |
|
2019
Q3 | $117K | Hold |
6,490
| – | – | ﹤0.01% | 3066 |
|
2019
Q2 | $106K | Hold |
6,490
| – | – | ﹤0.01% | 3082 |
|
2019
Q1 | $116K | Hold |
6,490
| – | – | ﹤0.01% | 3032 |
|
2018
Q4 | $123K | Hold |
6,490
| – | – | ﹤0.01% | 3030 |
|
2018
Q3 | $232K | Hold |
6,490
| – | – | ﹤0.01% | 2974 |
|
2018
Q2 | $135K | Hold |
6,490
| – | – | ﹤0.01% | 3095 |
|
2018
Q1 | $79K | Hold |
6,490
| – | – | ﹤0.01% | 3167 |
|
2017
Q4 | $70K | Hold |
6,490
| – | – | ﹤0.01% | 3186 |
|
2017
Q3 | $78K | Hold |
6,490
| – | – | ﹤0.01% | 3185 |
|
2017
Q2 | $111K | Hold |
6,490
| – | – | ﹤0.01% | 3152 |
|
2017
Q1 | $112K | Hold |
6,490
| – | – | ﹤0.01% | 3189 |
|
2016
Q4 | $111K | Hold |
6,490
| – | – | ﹤0.01% | 3215 |
|
2016
Q3 | $195K | Hold |
6,490
| – | – | ﹤0.01% | 3101 |
|
2016
Q2 | $184K | Hold |
6,490
| – | – | ﹤0.01% | 3161 |
|
2016
Q1 | $174K | Hold |
6,490
| – | – | ﹤0.01% | 3188 |
|
2015
Q4 | $313K | Hold |
6,490
| – | – | ﹤0.01% | 3015 |
|
2015
Q3 | $237K | Hold |
6,490
| – | – | ﹤0.01% | 3144 |
|
2015
Q2 | $245K | Hold |
6,490
| – | – | ﹤0.01% | 3202 |
|
2015
Q1 | $265K | Hold |
6,490
| – | – | ﹤0.01% | 3294 |
|
2014
Q4 | $265K | Hold |
6,490
| – | – | ﹤0.01% | 3294 |
|
2014
Q3 | $287K | Hold |
6,490
| – | – | ﹤0.01% | 3242 |
|
2014
Q2 | $282K | Hold |
6,490
| – | – | ﹤0.01% | 3275 |
|
2014
Q1 | $234K | Hold |
6,490
| – | – | ﹤0.01% | 3330 |
|
2013
Q4 | $260K | Hold |
6,490
| – | – | ﹤0.01% | 3217 |
|
2013
Q3 | $267K | Hold |
6,490
| – | – | ﹤0.01% | 3064 |
|
2013
Q2 | $251K | Buy |
+6,490
| New | +$251K | ﹤0.01% | 3010 |
|